NLRP3 and metabolic dysfunction-associated steatotic liver disease: In addition to fibrosis and hepatic stellate activation in the MetALD murine model, NLRP3 inflammasome activation was shown to contribute to steatosis and inflammation in MASLD and ALD, respectively [25,35,36,37].